Medicare billing address
CMS Medicare provider billing file
120 N 7Th St Ste 200Chambersburg, PA 17201
CMS public data · NPI 1790733798
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Louis L Glass, MD
Specialty
Credential
MD
NPI
1790733798
Primary source state
PA
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Louis L Glass, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
120 N 7Th St Ste 200CMS Doctors & Clinicians file
112 N 7Th StCMS Doctors & Clinicians file
112 N 7Th StCMS Doctors & Clinicians file
120 N 7Th StIn the 2024 CMS provider billing file, this NPI had 1,756 Medicare beneficiaries and 15,611 total services. The average beneficiary age was 76, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$557,167.08
Total Medicare payment amount
$418,669.84
Medicare beneficiaries
1,756
Total services
15,611
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Diabetes
36%
CMS beneficiary-panel share
Chronic kidney disease
35%
CMS beneficiary-panel share
Ischemic heart disease
35%
CMS beneficiary-panel share
Atrial fibrillation
23%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 4,750 | $6.04 |
| Injection, degarelix, 1 mg | 3,240 | $4.18 |
| Bcg live intravesical instillation, 1 mg | 2,002 | $2.86 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 1,328 | $85.46 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 717 | $120.22 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 462 | $176.60 |
| Automated urinalysis test | 454 | $2.19 |
| Ultrasound measurement of bladder capacity after voiding | 449 | $10.22 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 159 | $156.67 |
| Diagnostic exam of bladder and urethra using an endoscope | 144 | $220.72 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1790733798. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Tamsulosin Hcl | Tamsulosin Hcl | 2,398 | 5,977.6 | $48,929.52 |
| 2 | Finasteride | Finasteride | 1,790 | 4,926.5 | $26,468.13 |
| 3 | Amitriptyline Hcl | Amitriptyline Hcl | 535 | 1,022.8 | $6,723.44 |
| 4 | Solifenacin Succinate | Solifenacin Succinate | 351 | 656 | $11,188.17 |
| 5 | Myrbetriq | Mirabegron | 286 | 426 | $185,833.78 |
| 6 | Potassium Citrate Er | Potassium Citrate | 226 | 542 | $25,713.41 |
| 7 | Hydrochlorothiazide | Hydrochlorothiazide | 217 | 495.5 | $397.50 |
| 8 | Oxybutynin Chloride Er | Oxybutynin Chloride | 193 | 482.9 | $8,242.35 |
| 9 | Bicalutamide | Bicalutamide | 176 | 293 | $4,521.88 |
| 10 | Levofloxacin | Levofloxacin | 119 | 119 | $411.09 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
1991
Group/practice field
Wellspan Medical Group
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.